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Background:  Percutaneous ventricular assist devices (PVADs) offer an important but resource-intensive option for management of severe 
cardiogenic shock (CS). Optimal patient (pt) selection and duration of PVAD support remain poorly defined. We hypothesized that limited 
early hemodynamic and biochemical response to initiation of PVAD support was associated with increased in-hospital mortality.
methods:  We established a prospective quality improvement program among pts undergoing TandemHeart PVAD implantation for 
management of CS at a tertiary medical center. Laboratory and hemodynamic data before and after PVAD placement were collected as 
part of routine care.
results:  65 pts underwent PVAD implantation for CS in 2006-2014, of which 32 (49%) survived to discharge. Median duration of PVAD 
support was 5.8 d. 24h after PVAD placement, pts with an improvement in cardiac index ≤0.75 L/min/m2 had a higher risk of in-hospital 
death (OR 6.3, 95% CI 1.8-22.1). Considering severity of acidosis, pts with a decrease in serum anion gap ≤2 mEq/L had higher in-hospital 
mortality (OR 5.1, 95% CI 1.6-16.6). In a subset (n=11) of pts with serial serum lactates, mortality was markedly higher in those with a 
decrease in lactate ≤2 mmol/L (Fig).
conclusion:  Patients in CS with less robust hemodynamic improvement, persistent lactic acidosis, and elevated anion gap after 24h of 
PVAD support were less likely to survive to hospital discharge. These parameters may be used to inform decision-making about duration of 
PVAD support.
 
